SCHEMBL6217033

SCHEMBL6217033

COc1ccc(O)c(C2SC3=C(C(=O)CC(Cl)=C3)N2C(C)=O)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ TSHR P16473 1/20 0.33
▸ MTNR1B P49286 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ GAA P10253 3/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.31
▸ GFER P55789 1/20 0.31
▸ USP2 O75604 2/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ HCRTR1 O43613 1/20 0.31
▸ HCRTR2 O43614 1/20 0.31
▸ HSD17B3 P37058 1/20 0.30
▸ MAOA P21397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4486768 0.80 CYP3A4 (0.44) ALDH1A1CYP3A4MAPK1TSHRNPSR1
SCHEMBL4494668 0.78 CYP3A4 (0.37) ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL4515783 0.76 CYP3A4 (0.36) ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL4509024 0.76 CYP3A4 (0.35) CYP3A4
SCHEMBL4354365 0.72 BCHE (0.40) ALDH1A1CYP3A4HPGDMAPK1NPSR1
SCHEMBL4345823 0.70 CYP3A4 (0.42) ALDH1A1CYP3A4HPGDMAPK1MAPT
SCHEMBL4345682 0.65 HPGD (0.40) ALDH1A1CYP3A4HPGDMAPK1TSHR
SCHEMBL6184773 0.63 BCHE (0.42) ALDH1A1CYP3A4HPGDMAPK1NPSR1
SCHEMBL6217035 0.60 MAOB (0.36) ALDH1A1CYP3A4MAPK1MAPTALOX15
SCHEMBL10674390 0.57 LMNA (0.43) ALDH1A1CYP3A4HPGDMAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1496053-A1 KAPPA-OPIOID RECEPTOR AGONIST COMPRISING 2-PHENYLBENZOTHIAZOLINE DERIVATIVE SANTEN PHARMACEUTICAL CO., LTD. (JP) 2005-01-12 — — EP disclosed
Send feedback